Ming-chieh Tsai

Dr. Ming-chieh Tsai

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2021 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
CHChun-Ta Huang
Chun-Ta Huang
CLChi-Yu Lee
Chi-Yu Lee
HSHeng-You Sung
Heng-You Sung
SLShu-Jung Liu
Shu-Jung Liu
PLPo-Chih Liang
Po-Chih Liang
MTMing-chieh Tsai
Ming-chieh Tsai
Context: Individuals with diabetes mellitus (DM) are susceptible to various infections. Objective: We estimated the risk of herpes zoster (HZ) among individuals with DM compared with individuals in the general population. Methods: We searched the PubMed, Embase, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Cumulative Index to Nursing and Allied Health Literature, and PerioPath databases from their inception to January 30, 2021, for studies on the risk of HZ in individuals with DM. Two authors independently screened all articles identified. The same 2 authors independently extracted the data. Four case-control studies and 12 cohort studies were included. Results: Meta-analyses were performed using fixed and mixed-effects models. In the pooled analysis, individuals with DM had a higher risk of developing HZ (pooled relative risk [RR]: 1.38; 95% CI, 1.21-1.57) than individuals in the general population. The results were consistent in subgroup analyses stratified by type of diabetes, age, and study design. In individuals with DM, cardiovascular disease had an additive effect on increasing the risk of HZ (pooled RR: 1.19; 95% CI, 1.11-1.28). There was a linear dose-response association between age and the risk of HZ in individuals with DM. Conclusion: Individuals with DM have an increased risk of HZ compared with the general population. Varicella vaccination should be provided to individuals with DM regardless of their age, prioritizing older adults and those with cardiovascular disease. Varicella vaccination policies for individuals with DM should be updated based on the evidence.

12 November 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MTMing-chieh Tsai
Ming-chieh Tsai
TYTzu Lin Yeh
Tzu Lin Yeh
HHHsin-Yin Hsu
Hsin-Yin Hsu
LHLe-Yin Hsu
Le-Yin Hsu
CLChun-Chuan Lee
Chun-Chuan Lee
KCKuo-Liong Chien
Kuo-Liong Chien
The protective effect of different healthy lifestyle scores for the risk of cardiovascular disease (CVD) was reported, although the comparisons of performance were lacking. We compared the performance measures of CVDs from different healthy lifestyle scores among Taiwanese adults. We conducted a nationwide prospective cohort study of 6042 participants (median age 43 years, 50.2% women) in Taiwan’s Hypertensive, Hyperglycemia and Hyperlipidemia Survey, of whom 2002 were free of CVD at baseline. The simple and weighted the Mediterranean diet related healthy lifestyle (MHL) scores were defined as a combination of normal body mass index, Mediterranean diet, adequate physical activity, non-smokers, regular healthy drinking, and each dichotomous lifestyle factor. The World Cancer Research Fund and American Institute for Cancer Research cancer prevention recommended lifestyle and Life's Simple 7 following the guideline definition. The incidence of CVD among the four healthy lifestyle scores, each divided into four subgroups, was estimated. During a median 14.3 years follow-up period, 520 cases developed CVD. In the multivariate-adjusted Cox proportional hazard models, adherence to the highest category compared with the lowest one was associated with a lower incidence of CVD events, based on the simple (hazard ratio [HR] 0.43, 95% confidence interval [CI] 0.2–0.94) and weighted MHL scores (HR 0.44, 95% CI 0.28–0.68). Additionally, age played a role as a significant effect modifier for the protective effect of the healthy lifestyle scores for CVD risk. Specifically, the performance measures by integrated discriminative improvement showed a significant increase after adding the simple MHL score (integrated discriminative improvement: 0.51, 95% CI 0.16–0.86, P = 0.002) and weighted MHL score (integrated discriminative improvement: 0.38, 95% CI 0.01–0.74, P = 0.021). We demonstrated that the healthy lifestyle scores with an inverse association with CVD and reduced CVD risk were more likely for young adults than for old adults. Further studies to study the mechanism of the role of lifestyle on CVD prevention are warranted.

21 November 2022 in BMC Cancer
Verified
Journal Article
Open access
PDF file
TYTzu Lin Yeh
Tzu Lin Yeh
MHMin-Shu Hsu
Min-Shu Hsu
HHHsin-Yin Hsu
Hsin-Yin Hsu
MTMing-chieh Tsai
Ming-chieh Tsai
JJJing-Rong Jhuang
Jing-Rong Jhuang
KCKuo-Liong Chien
Kuo-Liong Chien
Background: The associations with cancer and cardiovascular diseases (CVD) had inconsistent results. The study aimed to investigate the risk of cardiovascular diseases (CVD) between populations with and without cancer. Methods: Patients with common cancers in Taiwan were enrolled in the study between 2007 and 2018 using the Taiwan Cancer Registry. We focused on colorectal cancer, women’s breast cancer, lung cancer, liver cancer, oral cancer, prostate cancer, and thyroid cancers. The study endpoint was fatal and non-fatal CVD, which was defined as ischemic heart disease and ischemic stroke according to the National Health Insurance Research Database. We compared the risk of CVD between patients with cancer and age- and sex-matched (1:1 ratio) participants who did not have cancer or CVD. Multivariable adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were obtained from Cox regression analysis. To evaluate the chronological trend, we estimated the HRs and 95% CI yearly since the diagnosis. Results: Among the 552,485 cancer patients (mean age, 60.6 years; women, 47.7%) during the median follow-up period of 4.1 years, 32,634 cases of fatal and non-fatal CVD were identified. Compared with that noted in the non-cancer population, the overall fully adjusted HR with 95% CI was 1.28 (1.25, 1.30) in the cancer population. The CVD risk was the highest in the first year, the adjusted HR with 95% CI was 2.31 (2.23, 2.40), and this risk decreased yearly. Conclusions: Patients with cancer had a significantly higher risk of fatal or non-fatal CVD. The risk was the highest in the first year since diagnosis and decreased yearly.

17 September 2022 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
WTWen-Hsuan Tsai
Wen-Hsuan Tsai
SKSiang-Ke Kong
Siang-Ke Kong
CLChu-Lin Lin
Chu-Lin Lin
KCKai-Hsuan Cheng
Kai-Hsuan Cheng
YCYi-Ting Cheng
Yi-Ting Cheng
MTMing-chieh Tsai
Ming-chieh Tsai

3 March 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
WTWen-Hsuan Tsai
Wen-Hsuan Tsai
YZYi-Hong Zeng
Yi-Hong Zeng
CLChun-Chuan Lee
Chun-Chuan Lee
MCMing-Nan Chien
Ming-Nan Chien
SLSung-Chen Liu
Sung-Chen Liu
MTMing-chieh Tsai
Ming-chieh Tsai
Objective: To determine the association between thyroid cancer and coronary artery disease, atrial fibrillation, cerebrovascular disease, and cardiovascular disease mortality.Methods: The PubMed, Embase, and Cochrane Library databases were searched for eligible studies from inception to September 22, 2022. Keywords included “thyroid cancer”, “atrial fibrillation”, “coronary artery disease”, “cerebrovascular disease”, and “mortality”. Primary outcomes included the incidence of coronary artery disease, cerebrovascular disease, atrial fibrillation, and cardiovascular disease mortality among patients with thyroid cancer. Secondary outcomes included cardiovascular disease events among those with thyroid cancer that received or did not receive radioactive iodine or lenvatinib. Estimates were pooled using fixed- and random-effects meta-analysis.Results: A total of 771,220 patients who underwent thyroidectomy in 15 studies were included. Risk for cerebrovascular disease (risk ratio [RR] 1.15 [95% confidence interval (CI) 1.10–1.21]) and atrial fibrillation [RR 1.59 (95% CI: 1.45–1.73)] were significantly increased. Risk for coronary artery disease was significantly increased [RR 1.12 (95% CI: 1.08–1.17)] in the common effect model. Cardiovascular disease mortality associated with thyroid cancer was not significant [RR 0.93 (95% CI: 0.59–1.45)]. Radioactive iodine had a neutral effect on cardiovascular disease [RR 1.00 (95% CI: 0.87–1.16)], and there was no beneficial nor harmful effect among different RAI doses.Conclusions: Thyroid cancer was significantly associated with a higher risk for cerebrovascular disease and atrial fibrillation; however, the hazard risk was not different between patients with and without radioactive iodine treatment. Thyroid cancer treatment should be individualized considering the potential harms and benefits to cardiovascular health.

20 February 2022 in Journal of Bone and Mineral Metabolism
Verified
Journal Article
Closed access
PDF file
WTWen-Hsuan Tsai
Wen-Hsuan Tsai
YZYi-Hong Zeng
Yi-Hong Zeng
CLChun-Chuan Lee
Chun-Chuan Lee
MTMing-chieh Tsai
Ming-chieh Tsai